BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34236404)

  • 1. PDGF-D activation by macrophage-derived uPA promotes AngII-induced cardiac remodeling in obese mice.
    Cheng YW; Zhang ZB; Lan BD; Lin JR; Chen XH; Kong LR; Xu L; Ruan CC; Gao PJ
    J Exp Med; 2021 Sep; 218(9):. PubMed ID: 34236404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perivascular Adipose Tissue-Derived PDGF-D Contributes to Aortic Aneurysm Formation During Obesity.
    Zhang ZB; Ruan CC; Lin JR; Xu L; Chen XH; Du YN; Fu MX; Kong LR; Zhu DL; Gao PJ
    Diabetes; 2018 Aug; 67(8):1549-1560. PubMed ID: 29794241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation.
    Riehle KJ; Johnson MM; Johansson F; Bauer RL; Hayes BJ; Gilbertson DG; Haran AC; Fausto N; Campbell JS
    Biochim Biophys Acta; 2014 Feb; 1842(2):318-25. PubMed ID: 24269585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The uPA/uPAR system regulates the bioavailability of PDGF-DD: implications for tumour growth.
    Ehnman M; Li H; Fredriksson L; Pietras K; Eriksson U
    Oncogene; 2009 Jan; 28(4):534-44. PubMed ID: 18997817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells.
    Ustach CV; Kim HR
    Mol Cell Biol; 2005 Jul; 25(14):6279-88. PubMed ID: 15988036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of macrophage-derived urokinase plasminogen activator in myocardial infarct repair: urokinase attenuates ventricular remodeling.
    Minami E; Castellani C; Malchodi L; Deem J; Bertko K; Meznarich J; Dishmon M; Murry CE; Stempien-Otero A
    J Mol Cell Cardiol; 2010 Sep; 49(3):516-24. PubMed ID: 20380835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator.
    Stempien-Otero A; Plawman A; Meznarich J; Dyamenahalli T; Otsuka G; Dichek DA
    J Biol Chem; 2006 Jun; 281(22):15345-51. PubMed ID: 16554301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luseogliflozin attenuates neointimal hyperplasia after wire injury in high-fat diet-fed mice via inhibition of perivascular adipose tissue remodeling.
    Mori Y; Terasaki M; Hiromura M; Saito T; Kushima H; Koshibu M; Osaka N; Ohara M; Fukui T; Ohtaki H; Tsutomu H; Yamagishi SI
    Cardiovasc Diabetol; 2019 Oct; 18(1):143. PubMed ID: 31672147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage p47
    Reddy SS; Agarwal H; Jaiswal A; Jagavelu K; Dikshit M; Barthwal MK
    Free Radic Biol Med; 2021 May; 168():168-179. PubMed ID: 33736980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation.
    Gupta KK; Donahue DL; Sandoval-Cooper MJ; Castellino FJ; Ploplis VA
    Sci Rep; 2017 Mar; 7(1):365. PubMed ID: 28336948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpressed connective tissue growth factor in cardiomyocytes attenuates left ventricular remodeling induced by angiotensin II perfusion.
    Zhang Y; Yan H; Guang GC; Deng ZR
    Clin Exp Hypertens; 2017; 39(2):168-174. PubMed ID: 28287886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-derived growth factor D induces cardiac fibrosis and proliferation of vascular smooth muscle cells in heart-specific transgenic mice.
    Pontén A; Folestad EB; Pietras K; Eriksson U
    Circ Res; 2005 Nov; 97(10):1036-45. PubMed ID: 16224065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice.
    Moriwaki H; Stempien-Otero A; Kremen M; Cozen AE; Dichek DA
    Circ Res; 2004 Sep; 95(6):637-44. PubMed ID: 15297377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of TCV-116 on endothelin-1 and PDGF A-chain expression in angiotensin II-induced hypertensive rats.
    Hara K; Kobayashi N; Nakano S; Mori Y; Tsubokou Y; Matsuoka H
    Hypertens Res; 2001 Jan; 24(1):55-64. PubMed ID: 11213031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urokinase plasminogen activator induces pro-fibrotic/m2 phenotype in murine cardiac macrophages.
    Meznarich J; Malchodi L; Helterline D; Ramsey SA; Bertko K; Plummer T; Plawman A; Gold E; Stempien-Otero A
    PLoS One; 2013; 8(3):e57837. PubMed ID: 23536772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation.
    Police SB; Thatcher SE; Charnigo R; Daugherty A; Cassis LA
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1458-64. PubMed ID: 19608970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II.
    Takayanagi T; Forrester SJ; Kawai T; Obama T; Tsuji T; Elliott KJ; Nuti E; Rossello A; Kwok HF; Scalia R; Rizzo V; Eguchi S
    Hypertension; 2016 Oct; 68(4):949-955. PubMed ID: 27480833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity.
    Pang C; Gao Z; Yin J; Zhang J; Jia W; Ye J
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E313-22. PubMed ID: 18492768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase-type plasminogen activator deficiency (uPA-KO) prevented carotid artery ligation-induced vascular remodeling in mice.
    Martin-McNulty B; Zhang L; da Cunha V; Vincelette J; Rutledge JC; Vergona R; Sullivan ME; Wang YX
    Transl Res; 2007 Feb; 149(2):70-5. PubMed ID: 17240317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis.
    Uutela M; Wirzenius M; Paavonen K; Rajantie I; He Y; Karpanen T; Lohela M; Wiig H; Salven P; Pajusola K; Eriksson U; Alitalo K
    Blood; 2004 Nov; 104(10):3198-204. PubMed ID: 15271796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.